YOLFTbeta
VentriPoint Diagnostics Ltd

VentriPoint Diagnostics Ltd

VPT · V · Healthcare / Medical Devices

0.065CAD-0.01 (-7.14%)

Price History

Full chart

Market Stats

Previous Close0.07
Open0.07
Day Range0.065 – 0.07
52-Week Range0.08 – 0.19
Volume84.53K
Market Cap16.39M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta0.20
50-Day Avg0.0988
200-Day Avg0.1163

About

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Hugh MacNaught
  • Employees0
  • Headquarters18 Hook Avenue, Toronto, ON, Canada, M6P 1T4, Canada
  • Websitehttps://ventripoint.com

Leadership

  • Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D.Executive Chairman & Corporate Secretary · b. 1952
  • Mr. Hugh MacNaughtCEO, President & Director
  • Mr. David Swetlow C.A., CPAChief Financial Officer
  • Mr. Hirotaka KatagiriCTO & Business Development Division Director
  • Mr. Matt DobsonMarketing Director
  • Mr. Jim GrabaApplication Specialist & Chief Trainer

Financials

Income Statement

Currency: CAD2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-----0151.72K372.29K71.02K128.31K55.78K209.48K38.91K60.18K81.02K36.02K068.17K49.18K95.17K179.93K
Growth (%)-------+145.38%-80.92%+80.67%-56.53%+275.52%-81.43%+54.68%+34.64%-55.55%-100.00%--27.85%+93.51%+89.06%
Cost of Revenue-----044.88K95.45K97.29K102.28K69.38K237.12K40.00K33.98K43.85K9.75K48.81K10.36K73.42K0-
Gross Profit-----0106.84K276.83K-26.27K26.04K-13.60K-27.64K-1.10K26.20K37.17K26.27K-48.81K57.81K-24.23K95.17K179.93K
Gross Margin------70.42%74.36%-37.00%20.29%-24.38%-13.19%-2.82%43.53%45.88%72.94%-84.80%-49.27%100.00%100.00%
Operating Expense-----2.63M4.17M5.21M3.28M1.98M1.99M2.03M3.39M3.85M3.32M1.92M3.67M4.97M4.91M4.90M3.58M
Operating Income-103.57K-41.98K-1.58M-5.06M-1.84M-2.63M-4.06M-4.93M-3.31M-1.96M-2.01M-2.06M-3.39M-3.82M-3.28M-1.89M-3.72M-4.91M-4.93M-4.80M-3.40M
Operating Margin-------2676.73%-1324.15%-4654.28%-1524.49%-3597.22%-984.31%-8718.55%-6353.31%-4051.66%-5245.01%--7203.96%-10024.81%-5045.41%-1889.37%
EBITDA-103.57K-41.98K-1.56M-4.99M-1.60M-2.29M-4.01M-4.88M-3.26M-2.06M-2.00M-1.74M-3.22M-3.79M-3.13M-1.59M-3.54M-4.73M-4.86M-4.76M-2.67M
EBITDA Margin-------2644.38%-1311.49%-4597.00%-1608.59%-3580.03%-830.46%-8282.66%-6303.58%-3865.27%-4415.68%--6944.32%-9889.25%-5001.96%-1481.50%
Net Income-103.64K-26.24K-1.38M-5.21M-1.84M-2.54M-3.36M-4.02M-1.65M-2.19M-1.51M-2.62M-3.70M-2.08M-3.32M-1.85M-3.88M-4.87M-4.87M-4.92M-3.20M
Net Income Margin-------2213.07%-1080.86%-2322.38%-1704.68%-2714.77%-1252.51%-9518.58%-3463.14%-4100.85%-5138.34%--7148.33%-9905.73%-5169.14%-1778.62%
R&D--941.09K3.18M682.35K911.58K1.90M2.73M1.77M630.00K723.42K1.16M1.18M1.45M1.04M272.04K457.34K1.05M1.08M969.24K372.91K
R&D as % of Total Revenue------1254.71%733.87%2492.85%490.99%1296.85%552.26%3030.22%2409.99%1288.57%755.31%-1540.91%2203.31%1018.41%207.26%
Interest Expense---9.16K185.36K293.37K361.63K309.65K445.18K610.10K782.20K438.14K32.89K093.83K229.31K12.96K28.16K58.43K179.72K525.57K
Interest Expense % of Total Revenue------238.35%83.17%626.85%475.48%1402.22%209.16%84.53%0.00%115.80%636.66%-41.31%118.80%188.83%292.10%

Balance Sheet

Currency: CAD2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets701.04K679.97K3.10M387.79K205.68K1.70M2.44M1.17M760.73K491.74K2.18M672.50K1.71M466.49K314.28K801.57K9.54M5.98M1.88M658.02K472.08K
Total Liabilities5.69K9.54K597.11K2.26M3.46M2.56M4.77M3.83M3.88M2.89M2.45M2.92M3.34M1.44M2.78M3.15M1.21M1.42M1.69M3.64M4.59M
Total Equity695.36K670.43K2.50M-1.87M-3.26M-860.18K-2.33M-2.65M-3.12M-2.40M-269.66K-2.25M-1.63M-973.26K-2.47M-2.35M8.33M4.55M189.71K-2.98M-4.12M
Cash696.13K9.65K890.22K61.86K24.75K1.40M1.89M459.78K365.80K172.13K1.98M191.28K1.36M66.57K13.76K526.03K9.27M5.19M1.29M60.55K55.39K
Total Debt---798.99K1.96M1.67M1.82M1.36M1.98M831.65K598.35K597.12K--1.13M1.37M159.97K459.08K274.38K--
Net Debt-696.13K-9.65K-890.22K737.13K1.94M272.19K-65.22K898.64K1.62M659.51K-1.38M405.84K-1.36M-66.57K1.11M843.84K-9.11M-4.73M-1.02M1.35M2.40M

Cash Flow

Currency: CAD2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.93K-37.40K-965.08K-4.20M-1.44M-2.03M-3.98M-4.37M-2.58M-1.26M-1.61M-2.20M-3.07M-3.05M-2.38M-1.10M-3.15M-4.14M-3.80M-3.39M-1.55M
Investing Cash Flow------45.44K-57.38K-24.57K-2.36K-26.71K-13.33K-13.33K-39.05K-27.37K-17.10K-3.76K-----
Financing Cash Flow700.06K-3.56M819.67K1.41M3.46M4.53M3.01M2.47M1.04M3.36M436.00K4.25M1.84M2.34M1.62M11.89M87.65K-102.36K2.20M1.53M
Capital Expenditure00117.67K129.77K045.45K58.58K24.45K2.52K31.01K6.81K13.99K39.05K27.37K17.10K3.76K4.26K0000
Free Cash Flow-3.93K-37.40K-1.08M-4.33M-1.44M-2.08M-4.04M-4.40M-2.59M-1.29M-1.61M-2.21M-3.11M-3.08M-2.40M-1.10M-3.15M-4.14M-3.80M-3.39M-1.55M
Dividends Paid-----------00000--000
FCF to OCF100.00%100.00%112.19%103.09%100.00%102.24%101.47%100.56%100.10%102.46%100.00%100.64%101.27%100.90%100.72%100.34%100.14%100.00%100.00%100.00%100.00%
Dividend Paid to FCF-----------0.00%0.00%0.00%0.00%0.00%--0.00%0.00%0.00%

Earnings

Report DateMar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021May 30, 2022Aug 29, 2022Nov 29, 2022Dec 31, 2022Jun 1, 2023
EPS Estimate-------------------------------------------------------------
EPS Actual-0.25-0.30-0.34-0.38-0.20-0.14-0.09-0.12-0.08-0.13-0.17-0.10-0.08-0.10-0.10-0.04-0.07-0.11-0.08-0.07-0.03-0.05-0.110.08-0.03-0.05-0.03-0.01-0.02-0.04-0.02-0.00-0.03-0.03-0.02-0.02-0.110.040.00-0.04-0.00-0.02-0.00-0.02-0.02-0.01-0.01-0.01-0.01-0.00-0.01-0.00-0.01-0.00-0.01-0.01-0.01-0.01-0.01-0.01-0.01
Surprise-------------------------------------------------------------
Timing--------------------------------------------------------After-hoursAfter-hoursAfter-hours-Pre-market

Key Statistics & Ratios

Market Cap16.39M
Enterprise Value18.68M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales110.94
Price / Book7.13
EPS-0.01
Book Value-0.02
Revenue (TTM)147.77K
Gross Profit (TTM)147.77K
EBITDA-3.40M
Profit Margin0.00%
Operating Margin-2594.09%
Return on Equity-2972.60%
Return on Assets-263.57%
Shares Outstanding192.88M
Shares Float189.84M
Beta0.20
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Dec 7, 20151:10